Normal view MARC view ISBD view

A Latin American field trial with a once-a-month oral contraceptive. [electronic resource]

By:

Leguia, A L

Producer: 19730606Description: 202-3 p. digitalISSN:

0024-7758

Subject(s):

In: The Journal of reproductive medicine vol. 10

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.

Back to results

1 In response to 'ezetimibe-induced hyperlipidaemia' case report.
by Bays, Harold
2 Striated muscle safety of ezetimibe/simvastatin (Vytorin).
by Davidson, Michael H
3 Intestinal sterol transporters and cholesterol absorption inhibition.
by Davis, Harry R
4 Management of dyslipidemia and hyperglycemia with a fixed-dose combination of sitagliptin and simvastatin.
by Steinberg, Helmut
5 Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
by Ose, Leiv
6 Effects of ezetimibe, simvastatin, atorvastatin, and ezetimibe-statin therapies on non-cholesterol sterols in patients with primary hypercholesterolemia.
by Assmann, Gerd
7 Effects of fenofibrate and ezetimibe, both as monotherapy and in coadministration, on cholesterol mass within lipoprotein subfractions and low-density lipoprotein peak particle size in patients with mixed hyperlipidemia.
by Tribble, Diane L
8 Changes in cholesterol absorption and cholesterol synthesis caused by ezetimibe and/or simvastatin in men.
by Sudhop, Thomas
9 The upper GI safety and tolerability of oral alendronate at a dose of 70 milligrams once weekly: a placebo-controlled endoscopy study.
by Lanza, Frank
10 Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia.
by Gagné, Claude
11 Muscle Complaints or Events in Patients Randomized to Simvastatin or Ezetimibe/Simvastatin.
by Nanna, Michael G
12 Effect on Fasting Serum Glucose Levels of Adding Ezetimibe to Statins in Patients With Nondiabetic Hypercholesterolemia.
by Toth, Peter P
13 Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: final baseline characteristics of the IMPROVE-IT study population.
by Blazing, Michael A
14 Indices of cholesterol metabolism and relative responsiveness to ezetimibe and simvastatin.
by Lakoski, Susan G
15 An update on the IMProved reduction of outcomes: Vytorin Efficacy International Trial (IMPROVE-IT) design.
by Califf, Robert M
16 Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): comparison of ezetimbe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromes.
by Cannon, Christopher P
17 Inhibition of intestinal cholesterol absorption with ezetimibe increases components of reverse cholesterol transport in humans.
by Davidson, Michael H
18 Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S). 1998.
by Pedersen, Terje R
19 Efficacy and safety of ezetimibe monotherapy in children with heterozygous familial or nonfamilial hypercholesterolemia.
by Kusters, D Meeike
20 On-treatment analysis of the Improved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE-IT).
by Blazing, Michael A